Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 10
2022 25
2023 24

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Biokinetics and Dosimetry of 177Lu-Pentixather.
Hänscheid H, Schirbel A, Hartrampf P, Kraus S, Werner RA, Einsele H, Wester HJ, Lassmann M, Kortüm M, Buck AK. Hänscheid H, et al. Among authors: hartrampf p. J Nucl Med. 2022 May;63(5):754-760. doi: 10.2967/jnumed.121.262295. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413147 Free article.
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC.
Hänscheid H, Hartrampf PE, Schirbel A, Buck AK, Lapa C. Hänscheid H, et al. Among authors: hartrampf pe. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2566-2572. doi: 10.1007/s00259-020-05177-z. Epub 2021 Jan 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33452632 Free PMC article.
Adrenal functional imaging - which marker for which indication?
Werner RA, Hartrampf PE, Schirbel A, Hahner S. Werner RA, et al. Among authors: hartrampf pe. Curr Opin Urol. 2022 Nov 1;32(6):585-593. doi: 10.1097/MOU.0000000000001040. Epub 2022 Sep 8. Curr Opin Urol. 2022. PMID: 36081395 Review.
PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy.
Hartrampf PE, Serfling SE, Michalski K, Buck AK, Werner RA. Hartrampf PE, et al. Semin Nucl Med. 2023 Jun 23:S0001-2998(23)00050-8. doi: 10.1053/j.semnuclmed.2023.06.003. Online ahead of print. Semin Nucl Med. 2023. PMID: 37357025 Review.
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy.
Steinhelfer L, Lunger L, Cala L, Pfob CH, Lapa C, Hartrampf PE, Buck AK, Schäfer H, Schmaderer C, Tauber R, Brosch-Lenz J, Haller B, Meissner VH, Knorr K, Weber WA, Eiber M. Steinhelfer L, et al. Among authors: hartrampf pe. J Nucl Med. 2023 Oct 19:jnumed.123.265986. doi: 10.2967/jnumed.123.265986. Online ahead of print. J Nucl Med. 2023. PMID: 37857504
Role of Functional SPECT and PET in Renal Emergencies.
Higuchi T, Hartrampf PE, Buck AK, Pomper MG, Rowe SP, Serfling SE, Werner RA. Higuchi T, et al. Among authors: hartrampf pe. Semin Nucl Med. 2023 Nov;53(6):786-796. doi: 10.1053/j.semnuclmed.2023.04.003. Epub 2023 May 24. Semin Nucl Med. 2023. PMID: 37236903 Review.
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection.
Lambertini A, Hartrampf PE, Higuchi T, Serfling SE, Meybohm P, Schirbel A, Buck AK, Werner RA. Lambertini A, et al. Among authors: hartrampf pe. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):228-229. doi: 10.1007/s00259-022-05932-4. Epub 2022 Aug 12. Eur J Nucl Med Mol Imaging. 2022. PMID: 35953728 Free PMC article. No abstract available.
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, Strosberg J. Askari E, et al. Among authors: hartrampf pe. J Nucl Med Technol. 2023 Mar;51(1):22-25. doi: 10.2967/jnmt.122.264904. Epub 2022 Oct 4. J Nucl Med Technol. 2023. PMID: 36195446 Review.
57 results